INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)
$12.12 -0.23 (-1.8623%)
Analysed INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) News Sources
ADMA vs Intellia Therapeutics: Which Biotech Stock Is a Better Pick Now?
27-05-2026
yahoo.com
Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026
01-06-2026
yahoo.com
High Growth Tech Stocks To Watch In US June 2026
03-06-2026
yahoo.com
Intellia (NTLA) Rockets 13% Ahead of Phase 3 Lonvo-Z Study Update
05-06-2026
yahoo.com
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05-06-2026
yahoo.com
Intellia Therapeutics, Inc. (NTLA) Buy Rating Reiterated Despite Share Offering Dilution
06-06-2026
yahoo.com
Exploring 3 High Growth Tech Stocks in the US Market
09-06-2026
yahoo.com
Intellia Therapeutics (NTLA) Down 7.9% Since Last Earnings Report: Can It Rebound?
10-06-2026
yahoo.com
Exploring High Growth Tech Stocks In The US Market
11-06-2026
yahoo.com
Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
13-06-2026
yahoo.com
What is the current price of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The current price of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is $12.12.
INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) absolute price change since previous trading day?
The absolute price change of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) since the previous trading day is $-0.23.
INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) percentage price change since previous trading day?
The percentage price change of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) since the previous trading day is -1.8623%.
What is the most recent average sentiment score for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The most recent average sentiment score for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The most recent sentiment for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is .
SEC-8K** Filing Available For INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.